Galera Therapeutics Inc. (GRTX) NASDAQ
$0.18 (0) (-1.07%)
Market Cap: $10.01M
As of 04/19/24 04:00 PM EDT. Market closed.
Galera Therapeutics Inc. (GRTX)
NASDAQ
$0.18
(0) (-1.07%)
Market Cap: $10.01M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
galera therapeutics, inc. is a pharmaceuticals company located in 101 lindenwood dr, malvern, pennsylvania, united ... read more
galera therapeutics, inc. is a pharmaceuticals company located in 101 lindenwood dr, malvern, pennsylvania, united states. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
41
URL
Address
.
PRICE CHART FOR GALERA THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.18
Previous Close
$0.19
Days Range
$0.18 - $0.19
52 week range
$0.09 - $3.59
Volume
804,210
Avg. Volume (30 days)
3,493,741
Market Cap
$10.01M
Dividend Yield
-
P/E
-
Shares Outstanding
54,392,170
Open
$0.18
Previous Close
$0.19
Days Range
$0.18 - $0.19
52 week range
$0.09 - $3.59
Volume
804,210
Avg. Volume (30 days)
3,493,741
Market Cap
$10.01M
Dividend Yield
-
P/E
-
Shares Outstanding
54,392,170
FINANCIAL STATEMENTS FOR GALERA THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GALERA THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Schneid Yair | 10% Owner | Jan 30, 2024 | Buy | $0.18 | 335,000 | 60,635 | 7,595,801 | Feb 26, 2024, 04:06 PM |
| Schneid Yair | 10% Owner | Jan 29, 2024 | Buy | $0.18 | 150,000 | 27,000 | 7,260,801 | Feb 26, 2024, 04:06 PM |
| Schneid Yair | 10% Owner | Feb 08, 2024 | Buy | $0.17 | 150,000 | 25,650 | 8,043,203 | Feb 26, 2024, 04:06 PM |
| Schneid Yair | 10% Owner | Feb 07, 2024 | Buy | $0.17 | 175,000 | 30,185 | 7,893,203 | Feb 26, 2024, 04:06 PM |
| Schneid Yair | 10% Owner | Feb 06, 2024 | Buy | $0.20 | 25,000 | 5,025 | 7,718,203 | Feb 26, 2024, 04:06 PM |
| Schneid Yair | 10% Owner | Feb 05, 2024 | Buy | $0.18 | 97,402 | 17,922 | 7,693,203 | Feb 26, 2024, 04:06 PM |
| Bachleda Mark | Chief Commercial Officer | Mar 16, 2023 | Buy | $2.25 | 11,000 | 24,717 | 11,000 | Mar 20, 2023, 04:05 PM |
| Sorensen Mel | President and CEO | Mar 10, 2023 | Buy | $1.68 | 100,000 | 168,120 | 332,044 | Mar 14, 2023, 08:30 AM |
| Degnan Chris | Chief Financial Officer | Mar 13, 2023 | Buy | $1.96 | 10,000 | 19,593 | 10,000 | Mar 14, 2023, 08:30 AM |
| Beardsley Robert A | Chief Operating Officer | Nov 21, 2022 | Option Exercise | $1.07 | 10,000 | 10,700 | 108,191 | Nov 22, 2022, 04:05 PM |
| Beardsley Robert A | Chief Operating Officer | Sep 12, 2022 | Option Exercise | $1.07 | 10,000 | 10,700 | 98,191 | Sep 13, 2022, 04:10 PM |
| West Linda | Director | Dec 17, 2021 | Buy | $2.74 | 20,000 | 54,804 | 60,000 | Dec 20, 2021, 06:30 PM |
| Beardsley Robert A | Chief Operating Officer | Dec 17, 2021 | Option Exercise | $1.07 | 20,000 | 21,400 | 88,191 | Dec 20, 2021, 06:30 PM |
| HOLMLUND JON T | Chief Medical Officer | Sep 01, 2021 | Option Exercise | $2.43 | 47,756 | 116,047 | 47,756 | Sep 03, 2021, 04:31 PM |
| HOLMLUND JON T | Chief Medical Officer | Sep 01, 2021 | Sale | $8.47 | 47,756 | 404,498 | 0 | Sep 03, 2021, 04:31 PM |
| West Linda | Director | Jun 15, 2021 | Buy | $9.13 | 10,000 | 91,300 | 40,000 | Jun 17, 2021, 06:41 PM |
| Alleva Lawrence M | Director | Jun 01, 2021 | Buy | $8.59 | 4,045 | 34,741 | 4,045 | Jun 03, 2021, 05:22 PM |
| West Linda | Director | May 28, 2021 | Buy | $8.64 | 10,000 | 86,410 | 10,000 | Jun 02, 2021, 05:35 PM |
| West Linda | Director | Jun 01, 2021 | Buy | $8.64 | 10,000 | 86,381 | 20,000 | Jun 02, 2021, 05:35 PM |
| Sorensen Mel | President and CEO | Mar 26, 2021 | Option Exercise | $1.09 | 217,015 | 235,492 | 232,044 | Mar 30, 2021, 04:42 PM |
| Novo Holdings A/S | 10% Owner | Feb 18, 2021 | Sale | $10.58 | 500,000 | 5,290,000 | 2,459,021 | Feb 19, 2021, 05:20 PM |
| Alleva Lawrence M | Director | Nov 13, 2020 | Buy | $10.22 | 2,325 | 23,771 | 6,325 | Nov 17, 2020, 04:06 PM |
| Sussman Joel F. | Chief Accounting Officer | Nov 12, 2020 | Option Exercise | $1.07 | 10,000 | 10,700 | 10,000 | Nov 16, 2020, 07:46 PM |
| Sussman Joel F. | Chief Accounting Officer | Nov 13, 2020 | Option Exercise | $1.46 | 10,000 | 14,552 | 10,000 | Nov 16, 2020, 07:46 PM |
| Sussman Joel F. | Chief Accounting Officer | Nov 12, 2020 | Sale | $10.06 | 10,000 | 100,627 | 0 | Nov 16, 2020, 07:46 PM |
| Sussman Joel F. | Chief Accounting Officer | Nov 13, 2020 | Sale | $10.32 | 10,000 | 103,197 | 0 | Nov 16, 2020, 07:46 PM |
| HOLMLUND JON T | Chief Medical Officer | Oct 26, 2020 | Option Exercise | $2.43 | 2,244 | 5,453 | 2,244 | Oct 28, 2020, 05:56 PM |
| HOLMLUND JON T | Chief Medical Officer | Oct 26, 2020 | Sale | $15.00 | 2,244 | 33,660 | 0 | Oct 28, 2020, 05:56 PM |
| Novo Holdings A/S | 10% Owner | Oct 15, 2020 | Sale | $11.00 | 450,000 | 4,950,000 | 2,959,021 | Oct 19, 2020, 04:34 PM |
| HOLMLUND JON T | Chief Medical Officer | Oct 06, 2020 | Option Exercise | $1.11 | 10,536 | 11,668 | 5,632 | Oct 07, 2020, 05:01 PM |
| HOLMLUND JON T | Chief Medical Officer | Oct 05, 2020 | Option Exercise | $1.07 | 100 | 107 | 100 | Oct 07, 2020, 05:01 PM |
| HOLMLUND JON T | Chief Medical Officer | Oct 05, 2020 | Sale | $12.00 | 100 | 1,200 | 0 | Oct 07, 2020, 05:01 PM |
| HOLMLUND JON T | Chief Medical Officer | Oct 06, 2020 | Sale | $12.00 | 10,536 | 126,432 | 0 | Oct 07, 2020, 05:01 PM |
| Novartis Bioventures Ltd | Former 10% Owner | Jun 19, 2020 | Sale | $8.25 | 1,001,312 | 8,260,824 | 2,467,961 | Jun 22, 2020, 04:52 PM |
| Novartis Bioventures Ltd | Former 10% Owner | Jun 18, 2020 | Sale | $9.04 | 900 | 8,136 | 3,469,273 | Jun 22, 2020, 04:52 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 15, 2020 | Sale | $9.05 | 6,164 | 55,784 | 3,483,395 | Jun 17, 2020, 05:47 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 17, 2020 | Sale | $9.27 | 4,622 | 42,846 | 3,470,173 | Jun 17, 2020, 05:47 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 16, 2020 | Sale | $9.30 | 8,600 | 79,980 | 3,474,795 | Jun 17, 2020, 05:47 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 12, 2020 | Sale | $9.19 | 1,500 | 13,785 | 3,489,559 | Jun 12, 2020, 06:33 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 11, 2020 | Sale | $9.21 | 7,200 | 66,312 | 3,491,059 | Jun 12, 2020, 06:33 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 10, 2020 | Sale | $9.46 | 8,532 | 80,713 | 3,498,259 | Jun 12, 2020, 06:33 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 05, 2020 | Sale | $9.66 | 8,652 | 83,578 | 3,519,450 | Jun 09, 2020, 08:02 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 09, 2020 | Sale | $9.38 | 7,000 | 65,660 | 3,506,791 | Jun 09, 2020, 08:02 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 08, 2020 | Sale | $9.66 | 5,659 | 54,666 | 3,513,791 | Jun 09, 2020, 08:02 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 04, 2020 | Sale | $9.55 | 4,088 | 39,040 | 3,528,102 | Jun 04, 2020, 05:36 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 03, 2020 | Sale | $9.78 | 5,208 | 50,934 | 3,532,190 | Jun 04, 2020, 05:36 PM |
| Novartis Bioventures Ltd | 10% Owner | Jun 02, 2020 | Sale | $9.68 | 5,669 | 54,876 | 3,537,398 | Jun 04, 2020, 05:36 PM |
| HOLMLUND JON T | Chief Medical Officer | May 26, 2020 | Option Exercise | $1.07 | 692 | 740 | 692 | May 28, 2020, 04:50 PM |
| HOLMLUND JON T | Chief Medical Officer | May 26, 2020 | Sale | $12.00 | 692 | 8,304 | 0 | May 28, 2020, 04:50 PM |
| HOLMLUND JON T | Chief Medical Officer | May 21, 2020 | Option Exercise | $1.07 | 1,174 | 1,256 | 1,174 | May 22, 2020, 05:20 PM |
| HOLMLUND JON T | Chief Medical Officer | May 20, 2020 | Option Exercise | $1.07 | 969 | 1,037 | 969 | May 22, 2020, 05:20 PM |
| HOLMLUND JON T | Chief Medical Officer | May 20, 2020 | Sale | $12.00 | 969 | 11,628 | 0 | May 22, 2020, 05:20 PM |
| HOLMLUND JON T | Chief Medical Officer | May 21, 2020 | Sale | $12.00 | 1,174 | 14,088 | 0 | May 22, 2020, 05:20 PM |
| HOLMLUND JON T | Chief Medical Officer | May 11, 2020 | Option Exercise | $1.07 | 185 | 198 | 185 | May 12, 2020, 07:00 PM |
| HOLMLUND JON T | Chief Medical Officer | May 08, 2020 | Option Exercise | $1.07 | 5,102 | 5,459 | 5,102 | May 12, 2020, 07:00 PM |
| HOLMLUND JON T | Chief Medical Officer | May 12, 2020 | Option Exercise | $1.07 | 671 | 718 | 671 | May 12, 2020, 07:00 PM |
| HOLMLUND JON T | Chief Medical Officer | May 08, 2020 | Sale | $12.00 | 5,102 | 61,224 | 0 | May 12, 2020, 07:00 PM |
| HOLMLUND JON T | Chief Medical Officer | May 12, 2020 | Sale | $12.00 | 671 | 8,052 | 0 | May 12, 2020, 07:00 PM |
| HOLMLUND JON T | Chief Medical Officer | May 11, 2020 | Sale | $12.00 | 185 | 2,220 | 0 | May 12, 2020, 07:00 PM |
| HOLMLUND JON T | Chief Medical Officer | May 06, 2020 | Option Exercise | $1.07 | 1,489 | 1,593 | 1,489 | May 07, 2020, 07:12 PM |
| HOLMLUND JON T | Chief Medical Officer | May 05, 2020 | Option Exercise | $1.07 | 3,064 | 3,278 | 3,064 | May 07, 2020, 07:12 PM |
| HOLMLUND JON T | Chief Medical Officer | May 07, 2020 | Option Exercise | $1.07 | 2,059 | 2,203 | 2,059 | May 07, 2020, 07:12 PM |
| HOLMLUND JON T | Chief Medical Officer | May 05, 2020 | Sale | $12.16 | 3,064 | 37,258 | 0 | May 07, 2020, 07:12 PM |
| HOLMLUND JON T | Chief Medical Officer | May 07, 2020 | Sale | $12.00 | 2,059 | 24,709 | 0 | May 07, 2020, 07:12 PM |
| HOLMLUND JON T | Chief Medical Officer | May 06, 2020 | Sale | $12.00 | 1,489 | 17,868 | 0 | May 07, 2020, 07:12 PM |
| Alleva Lawrence M | Director | Dec 13, 2019 | Buy | $9.78 | 4,000 | 39,139 | 4,000 | Dec 17, 2019, 04:05 PM |
| Clarus IV-A, L.P. | 10% Owner | Nov 12, 2019 | Buy | $12.00 | 250,000 | 3,000,000 | 652,324 | Nov 14, 2019, 05:00 PM |
| Blackstone Clarus GP L.P. | 10% Owner | Nov 12, 2019 | Buy | $12.00 | 250,000 | 3,000,000 | 652,324 | Nov 14, 2019, 05:00 PM |
| Novo Holdings A/S | 10% Owner | Nov 12, 2019 | Buy | $12.00 | 500,000 | 6,000,000 | 3,409,021 | Nov 14, 2019, 02:16 PM |
| New Enterprise Associates 14, L.P. | 10% Owner | Nov 12, 2019 | Buy | $12.00 | 416,666 | 4,999,992 | 4,358,047 | Nov 12, 2019, 05:00 PM |
| Sofinnova Venture Partners IX, L.P. | 10% Owner | Nov 12, 2019 | Buy | $12.00 | 750,000 | 9,000,000 | 3,083,712 | Nov 12, 2019, 04:17 PM |
| Novartis Bioventures Ltd | 10% Owner | Nov 12, 2019 | Buy | $12.00 | 250,000 | 3,000,000 | 3,543,067 | Nov 12, 2019, 04:15 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Schneid Yair | 10% Owner | 01/30/2024 | 60,635 |
| Schneid Yair | 10% Owner | 01/29/2024 | 27,000 |
| Schneid Yair | 10% Owner | 02/08/2024 | 25,650 |
| Schneid Yair | 10% Owner | 02/07/2024 | 30,185 |
| Schneid Yair | 10% Owner | 02/06/2024 | 5,025 |
| Schneid Yair | 10% Owner | 02/05/2024 | 17,922 |
| Bachleda Mark | Chief Commercial Officer | 03/16/2023 | 24,717 |
| Sorensen Mel | President and CEO | 03/10/2023 | 168,120 |
| Degnan Chris | Chief Financial Officer | 03/13/2023 | 19,593 |
| Beardsley Robert A | Chief Operating Officer | 11/21/2022 | 10,700 |
| Beardsley Robert A | Chief Operating Officer | 09/12/2022 | 10,700 |
| West Linda | Director | 12/17/2021 | 54,804 |
| Beardsley Robert A | Chief Operating Officer | 12/17/2021 | 21,400 |
| HOLMLUND JON T | Chief Medical Officer | 09/01/2021 | 116,047 |
| HOLMLUND JON T | Chief Medical Officer | 09/01/2021 | 404,498 |
| West Linda | Director | 06/15/2021 | 91,300 |
| Alleva Lawrence M | Director | 06/01/2021 | 34,741 |
| West Linda | Director | 05/28/2021 | 86,410 |
| West Linda | Director | 06/01/2021 | 86,381 |
| Sorensen Mel | President and CEO | 03/26/2021 | 235,492 |
| Novo Holdings A/S | 10% Owner | 02/18/2021 | 5,290,000 |
| Alleva Lawrence M | Director | 11/13/2020 | 23,771 |
| Sussman Joel F. | Chief Accounting Officer | 11/12/2020 | 10,700 |
| Sussman Joel F. | Chief Accounting Officer | 11/13/2020 | 14,552 |
| Sussman Joel F. | Chief Accounting Officer | 11/12/2020 | 100,627 |
| Sussman Joel F. | Chief Accounting Officer | 11/13/2020 | 103,197 |
| HOLMLUND JON T | Chief Medical Officer | 10/26/2020 | 5,453 |
| HOLMLUND JON T | Chief Medical Officer | 10/26/2020 | 33,660 |
| Novo Holdings A/S | 10% Owner | 10/15/2020 | 4,950,000 |
| HOLMLUND JON T | Chief Medical Officer | 10/06/2020 | 11,668 |
| HOLMLUND JON T | Chief Medical Officer | 10/05/2020 | 107 |
| HOLMLUND JON T | Chief Medical Officer | 10/05/2020 | 1,200 |
| HOLMLUND JON T | Chief Medical Officer | 10/06/2020 | 126,432 |
| Novartis Bioventures Ltd | Former 10% Owner | 06/19/2020 | 8,260,824 |
| Novartis Bioventures Ltd | Former 10% Owner | 06/18/2020 | 8,136 |
| Novartis Bioventures Ltd | 10% Owner | 06/15/2020 | 55,784 |
| Novartis Bioventures Ltd | 10% Owner | 06/17/2020 | 42,846 |
| Novartis Bioventures Ltd | 10% Owner | 06/16/2020 | 79,980 |
| Novartis Bioventures Ltd | 10% Owner | 06/12/2020 | 13,785 |
| Novartis Bioventures Ltd | 10% Owner | 06/11/2020 | 66,312 |
| Novartis Bioventures Ltd | 10% Owner | 06/10/2020 | 80,713 |
| Novartis Bioventures Ltd | 10% Owner | 06/05/2020 | 83,578 |
| Novartis Bioventures Ltd | 10% Owner | 06/09/2020 | 65,660 |
| Novartis Bioventures Ltd | 10% Owner | 06/08/2020 | 54,666 |
| Novartis Bioventures Ltd | 10% Owner | 06/04/2020 | 39,040 |
| Novartis Bioventures Ltd | 10% Owner | 06/03/2020 | 50,934 |
| Novartis Bioventures Ltd | 10% Owner | 06/02/2020 | 54,876 |
| HOLMLUND JON T | Chief Medical Officer | 05/26/2020 | 740 |
| HOLMLUND JON T | Chief Medical Officer | 05/26/2020 | 8,304 |
| HOLMLUND JON T | Chief Medical Officer | 05/21/2020 | 1,256 |
| HOLMLUND JON T | Chief Medical Officer | 05/20/2020 | 1,037 |
| HOLMLUND JON T | Chief Medical Officer | 05/20/2020 | 11,628 |
| HOLMLUND JON T | Chief Medical Officer | 05/21/2020 | 14,088 |
| HOLMLUND JON T | Chief Medical Officer | 05/11/2020 | 198 |
| HOLMLUND JON T | Chief Medical Officer | 05/08/2020 | 5,459 |
| HOLMLUND JON T | Chief Medical Officer | 05/12/2020 | 718 |
| HOLMLUND JON T | Chief Medical Officer | 05/08/2020 | 61,224 |
| HOLMLUND JON T | Chief Medical Officer | 05/12/2020 | 8,052 |
| HOLMLUND JON T | Chief Medical Officer | 05/11/2020 | 2,220 |
| HOLMLUND JON T | Chief Medical Officer | 05/06/2020 | 1,593 |
| HOLMLUND JON T | Chief Medical Officer | 05/05/2020 | 3,278 |
| HOLMLUND JON T | Chief Medical Officer | 05/07/2020 | 2,203 |
| HOLMLUND JON T | Chief Medical Officer | 05/05/2020 | 37,258 |
| HOLMLUND JON T | Chief Medical Officer | 05/07/2020 | 24,709 |
| HOLMLUND JON T | Chief Medical Officer | 05/06/2020 | 17,868 |
| Alleva Lawrence M | Director | 12/13/2019 | 39,139 |
| Clarus IV-A, L.P. | 10% Owner | 11/12/2019 | 3,000,000 |
| Blackstone Clarus GP L.P. | 10% Owner | 11/12/2019 | 3,000,000 |
| Novo Holdings A/S | 10% Owner | 11/12/2019 | 6,000,000 |
| New Enterprise Associates 14, L.P. | 10% Owner | 11/12/2019 | 4,999,992 |
| Sofinnova Venture Partners IX, L.P. | 10% Owner | 11/12/2019 | 9,000,000 |
| Novartis Bioventures Ltd | 10% Owner | 11/12/2019 | 3,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN GALERA THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKSTONE INC. | 1,678,984 | 0.00109% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 440,349 | 0.00001% | 40.59% | Other |
| BLACKROCK INC. | 357,622 | 0% | -3.51% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 313,500 | 0.00007% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR GALERA THERAPEUTICS INC
STOCK BUYBACKS FOR GALERA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-2.04%
1Q
06/30/2023
3.80%
2Q
03/31/2023
26.57%
3Q
09/30/2022
66.08%
5Q
06/30/2022
66.10%
6Q
03/31/2022
66.54%
7Q
12/31/2021
68.43%
8Q
09/30/2021
69.36%
9Q
06/30/2021
75.38%
10Q
03/31/2021
78.28%
11Q
12/31/2020
78.51%
12Q
09/30/2020
79.09%
13Q
06/30/2020
79.40%
14Q
03/31/2020
79.53%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GALERA THERAPEUTICS INC
LOADING...